REPORT TO THE PRESIDENT
THE DEPLOYMENT OF CHEM AGENT WITHIN CONUS
Submitted by
Director of Consolidated Intelligence Agency
TOP SECRET
SPECIAL ACCESS
REPORT TO THE PRESIDENT ON
THE DEPLOYMENT OF CHEMICAL AGENT WITHIN CONUS
Executive Summary
The Red Horse bio agent is e
Ebola virus without the attending fragility one would expect of a tropical virus in temperate or
high-altitude climates. Under this administration’s Directive 21-03 “Eye for an Eye,” clinical trials of
the replicated Red Horse strain against interred Islamic jihadist prisoners resulted in 100% mortality
within 48 hour
Interestingly, whereas Ebola patients suffer tremendous and incapacitating pain, Red Horse
subjects acquire a degree of homicidal psychosis that can blind
impending mortality.
This video, of captured U.S. Diplo
Upon inhalation, Red Horse patients begin to bleed out. Massive hemorrhaging follows with
subjects bleeding from lachrymal ducts, ears (via cerebral spinal fluid) anus and urethra. In 65% of
those subjects tested, ext
within 45 minutes. Unlike Ebola, full hemorrhagic fever did not present, nor did patients live long
enough to manifest symptoms of necrotic organ tissu
determined to be massive hypovolemic shock.
Development
Approximately two yea
discovered within a laboratory facility inside the Caspian port-sector of Cheleken, Turkmenistan.
The facility poses as an environmental testing facility b
operations.
Assets in-theatre tracked delivery of Red Horse by air into Dushanbe, Tajikistan. Hand-off of the
agent to known jiha
subsequent delivery by land south across the Vaksh River to a village of approximately 15
families outside of Kulyab.
The agent was then dispersed. Sat recon suggests a portable pesticide sprayer was used.
The agent proved 100% effective within the village. From Patient 0 to Patient Om
persons) it is believed that 51 hours had elapsed.
While Tajik nationals are not overt s
serious antipathy. It is reasonable to believe that this Kulyab Event was a beta test of Red Horse
prior to deployment against CO
Following the Kulyab Eve
sample of Red Horse and plans for a Site B contingency test location, also in Tajikistan.
Subsequently we received the Jed Mather video. It is clear that jihadist cells have sufficient
quantities of this virus that they want us to kn
The Tajik Red Horse trial proved that the agent is sufficiently deadly that a full TRVA was
conducted. A vaccine development program has proven to be a qualified success, but has
demonstrated several symptoms that cannot, as of this date, be countered without diminishing the
efficacy of the vac
Conclusion
CIA threat-risk-vulnerability analysis concludes that Red Horse presents a dir
Administration and its backers. Because Red Horse is believed to be at the disposal of
dispersed jihadist ope
recommendation of the CIA that:
•Continued discretionary fun
Red Horse vaccine;
•Existing supplies of the vaccine be provided for National Command Authority, the most
senior strategic positions of the Administration and key corporate and religious figures,
then increasing distribution to less
•Restrict all knowledge of Red Horse to this distribution list’s eyes only to permit deniability
and mitig
Should Red Horse fall under the umbrella of public scrutiny, we should anticipate a panic with
severe repercussions t
public scare uncontained by official Vox channels risks provoking a
jihadist operatives inside CONUS.
Copy to:
Director, Defense Research and Engineering
General Counsel of the Department of Defense
Chairman, Cedocor
Brand Director, VOX
Chief Executive Officer, CDC
Board of Directors, Halli-Bech Reyn
Chairman of the Synod, New Evangelical Church
CC: Special Operations Director, Bureau of Morality
REPORT TO THE PRESIDENT
THE DEPLOYMENT OF CHEM AGENT WITHIN CONUS
Submitted by
Director of Consolidated Intelligence Agency
TOP SECRET
SPECIAL ACCESS
REPORT TO THE PRESIDENT ON
THE DEPLOYMENT OF CHEMICAL AGENT WITHIN CONUS
Executive Summary
The Red Horse bio agent is extremely hardy, presenting many of the same symptoms of the
Ebola virus without the attending fragility one would expect of a tropical virus in temperate or
high-altitude climates. Under this administration’s Directive 21-03 “Eye for an Eye,” clinical trials of
the replicated Red Horse strain against interred Islamic jihadist prisoners resulted in 100% mortality
within 48 hours of exposure.
Interestingly, whereas Ebola patients suffer tremendous and incapacitating pain, Red Horse
subjects acquire a degree of homicidal psychosis that can blind the subject to his own pain and
impending mortality.
This video, of captured U.S. Diplomat Jed Mather, shows the effects of the virus.
Upon inhalation, Red Horse patients begin to bleed out. Massive hemorrhaging follows with
subjects bleeding from lachrymal ducts, ears (via cerebral spinal fluid) anus and urethra. In 65% of
those subjects tested, external stressors exacerbated the hemorrhage resulting in full mortality
within 45 minutes. Unlike Ebola, full hemorrhagic fever did not present, nor did patients live long
enough to manifest symptoms of necrotic organ tissue. In all cases, cause of death was
determined to be massive hypovolemic shock.
Development
Approximately two years ago, a weaponized biological agent code-named Red Horse was
discovered within a laboratory facility inside the Caspian port-sector of Cheleken, Turkmenistan.
The facility poses as an environmental testing facility but is known to be a hub for jihadist CBRN
operations.
Assets in-theatre tracked delivery of Red Horse by air into Dushanbe, Tajikistan. Hand-off of the
agent to known jihadist sympathizers was captured before vectoring a UAV asset to follow
subsequent delivery by land south across the Vaksh River to a village of approximately 15
families outside of Kulyab.
The agent was then dispersed. Sat recon suggests a portable pesticide sprayer was used.
The agent proved 100% effective within the village. From Patient 0 to Patient Omega, (73
persons) it is believed that 51 hours had elapsed.
While Tajik nationals are not overt sponsors of the jihadist movement, Muslim sympathies negate
serious antipathy. It is reasonable to believe that this Kulyab Event was a beta test of Red Horse
prior to deployment against CONUS.
Following the Kulyab Event, our assets recovered the Tajik courier, Hamid Al-Mahvand, a second
sample of Red Horse and plans for a Site B contingency test location, also in Tajikistan.
Subsequently we received the Jed Mather video. It is clear that jihadist cells have sufficient
quantities of this virus that they want us to know that they have it.
The Tajik Red Horse trial proved that the agent is sufficiently deadly that a full TRVA was
conducted. A vaccine development program has proven to be a qualified success, but has
demonstrated several symptoms that cannot, as of this date, be countered without diminishing the
efficacy of the vaccine.
Conclusion
CIA threat-risk-vulnerability analysis concludes that Red Horse presents a dire threat to both the
Administration and its backers. Because Red Horse is believed to be at the disposal of
dispersed jihadist operatives that may or may not be currently within CONUS, it is the
recommendation of the CIA that:
•Continued discretionary funding be diverted to increase safer, faster production of the
Red Horse vaccine;
•Existing supplies of the vaccine be provided for National Command Authority, the most
senior strategic positions of the Administration and key corporate and religious figures,
then increasing distribution to less-senior positions as inventory permits; and,
•Restrict all knowledge of Red Horse to this distribution list’s eyes only to permit deniability
and mitigate panic.
Should Red Horse fall under the umbrella of public scrutiny, we should anticipate a panic with
severe repercussions to both economic and foreign policies. Considering Red Horse’s efficacy, a
public scare uncontained by official Vox channels risks provoking a “use it or lose it” attitude among
jihadist operatives inside CONUS.
Copy to:
Director, Defense Research and Engineering
General Counsel of the Department of Defense
Chairman, Cedocore Industries
Brand Director, VOX
Chief Executive Officer, CDC
Board of Directors, Halli-Bech Reynolds
Chairman of the Synod, New Evangelical Church
CC: Special Operations Director, Bureau of Morality
24.9.2